SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 1,048,594 shares at $5.69 ($5.8M) on 2025-10-06, disclosed to the SEC on 2025-10-07.
Scheduled sale ($5.8M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.56 | 450,342 | $2.5M | 42.8% |
| 2 | $5.56 | 450,342 | $2.5M | 42.8% |
| 3 | $5.69 | 73,955 | $421K | 7.2% |
| 4 | $5.69 | 73,955 | $421K | 7.2% |
| Total | $5.58 avg | 1,048,594 | $5.8M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |